GlassScriptPhysician profile
Darrell B Leslie
NPI 1588741755
$688.81
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $168 · 2021: $35.88 · 2022: $56.93 · 2023: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $176.02 | 2019-2020 | |
| Abbvie INC. | $163.62 | 2019-2023 | |
| Dexcom, INC. | $91.07 | 2022-2023 | Dexcom G6 Transmitter |
| Amgen INC. | $89.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $31.21 | 2020 | |
| Antares Pharma, INC. | $17.52 | 2019 | |
| Lilly USA, LLC | $15.58 | 2020 | |
| Si-Bone, INC. | $15.46 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.37 | 2023 | |
| Glaxosmithkline, LLC. | $14.30 | 2019 | |
| Pfizer INC. | $12.48 | 2019 | |
| Eisai INC. | $11.98 | 2021 | |
| Abbott Laboratories | $11.93 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.80 | 2019 | |
| Horizon Therapeutics Plc | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Leslie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.